Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Dianthus Therapeutics (DNTH) Return on Assets: 2018-2025

Historic Return on Assets for Dianthus Therapeutics (DNTH) over the last 5 years, with Sep 2025 value amounting to -0.28%.

  • Dianthus Therapeutics' Return on Assets fell 9.00% to -0.28% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.28%, marking a year-over-year decrease of 9.00%. This contributed to the annual value of -0.31% for FY2024, which is 3.00% up from last year.
  • Per Dianthus Therapeutics' latest filing, its Return on Assets stood at -0.28% for Q3 2025, which was up 18.03% from -0.34% recorded in Q2 2025.
  • In the past 5 years, Dianthus Therapeutics' Return on Assets ranged from a high of -0.15% in Q2 2024 and a low of -0.51% during Q1 2023.
  • Moreover, its 3-year median value for Return on Assets was -0.28% (2025), whereas its average is -0.29%.
  • Per our database at Business Quant, Dianthus Therapeutics' Return on Assets spiked by 33bps in 2024 and then dropped by 19bps in 2025.
  • Over the past 4 years, Dianthus Therapeutics' Return on Assets (Quarterly) stood at -0.44% in 2022, then rose by 21bps to -0.23% in 2023, then remained steady at -0.23% in 2024, then fell by 9bps to -0.28% in 2025.
  • Its Return on Assets was -0.28% in Q3 2025, compared to -0.34% in Q2 2025 and -0.28% in Q1 2025.